Clinuvel Pharmaceuticals Limited (ASX:CUV)
12.31
+0.08 (0.65%)
Aug 15, 2025, 4:12 PM AEST
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 615.62 million as of August 15, 2025. Its market cap has decreased by -10.07% in one year.
Market Cap
615.62M
Enterprise Value
418.11M
Revenue
91.02M
Ranking
n/a
PE Ratio
16.00
Stock Price
12.31
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 615.62M, an increase of 11,680.70%. That is a compound annual growth rate of 21.47%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 130.79B |
Pro Medicus | 32.98B |
Cochlear | 20.01B |
Sonic Healthcare | 14.07B |
Ramsay Health Care | 9.02B |
Telix Pharmaceuticals | 5.76B |
Ansell | 4.58B |
Mesoblast | 3.11B |